Company overview

We are a science-driven biotechnology company dedicated to the development of next-generation immuno-oncology therapies.

Science & Technology
Integrated proprietary R&D engine anchored around our deep understanding of tumor immunology, continuously driving the discovery and development of innovative next-generation immunotherapies.
Science & Technology
We have established an integrated in-house R&D platform that covers target selection and validation, drug discovery, high-throughput screening, molecule design, preclinical studies, CMC and IND-enabling capabilities.